Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
July 26, 2016
Prophylactic cranial irradiation in small cell lung cancer: A single institution experience
Luke Nicholls, Gregory J Keir, Michelle A Murphy, et al.
Respirology Case Reports
|
October 26, 2022
Pulmonary involvement in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis: A single centre case series
Peter T Bell, Robert Sheehy, Luke Droney, et al.
Thorax
|
October 16, 2013
Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants
Simon L F Walsh, Nicola Sverzellati, Anand Devaraj, et al.
Journal of Clinical Medicine
|
May 5, 2017
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
Adelle S Jee, Stephen Adelstein, Jane Bleasel, et al.
Arthritis and Rheumatism
|
July 20, 2011
Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests
Benjamin E Schreiber, Christopher J Valerio, Gregory J Keir, et al.
Thorax
|
September 14, 2013
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Gregory J Keir, Benjamin Garfield, David M Hansell, et al.
Pulmonary Circulation
|
September 25, 2015
Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection
Gregory J Keir, Arjun Nair, Stamatia Giannarou, et al.
The European Respiratory Journal
|
January 28, 2012
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy
Gregory J Keir, Toby M Maher, David M Hansell, et al.
Respirology (Carlton, Vic.)
|
November 30, 2013
Rituximab in severe, treatment-refractory interstitial lung disease
Gregory J Keir, Toby M Maher, Damien Ming, et al.
Trials
|
June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
Peter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Asia-Pacific Journal of Clinical Oncology
|
July 26, 2016
Prophylactic cranial irradiation in small cell lung cancer: A single institution experience
Luke Nicholls, Gregory J Keir, Michelle A Murphy, et al.
Respirology Case Reports
|
October 26, 2022
Pulmonary involvement in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis: A single centre case series
Peter T Bell, Robert Sheehy, Luke Droney, et al.
Thorax
|
October 16, 2013
Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants
Simon L F Walsh, Nicola Sverzellati, Anand Devaraj, et al.
Journal of Clinical Medicine
|
May 5, 2017
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
Adelle S Jee, Stephen Adelstein, Jane Bleasel, et al.
Arthritis and Rheumatism
|
July 20, 2011
Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests
Benjamin E Schreiber, Christopher J Valerio, Gregory J Keir, et al.
Thorax
|
September 14, 2013
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Gregory J Keir, Benjamin Garfield, David M Hansell, et al.
Pulmonary Circulation
|
September 25, 2015
Pulmonary vasospasm in systemic sclerosis: noninvasive techniques for detection
Gregory J Keir, Arjun Nair, Stamatia Giannarou, et al.
The European Respiratory Journal
|
January 28, 2012
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy
Gregory J Keir, Toby M Maher, David M Hansell, et al.
Respirology (Carlton, Vic.)
|
November 30, 2013
Rituximab in severe, treatment-refractory interstitial lung disease
Gregory J Keir, Toby M Maher, Damien Ming, et al.
Trials
|
June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
Peter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Page
of 3